What happens when we work on your research.
The ecDNA project below is built from a published Nature paper on extrachromosomal DNA (ecDNA). It's the clearest way to see how Clario works — from a dense, technical paper to the strategic assets an investor or the public would actually act on.
Five deliverables, one complete read of the science.
"Why Should You Invest" Brief
Answers the exact question a funding committee is silently asking, instead of leaving them to infer it from a dense paper.
"Why It Matters" Document
Translates the scientific significance of ecDNA research into stakes a non-scientist can immediately grasp.
Simplified Research Summary
A 1–2 page distillation of the full paper, written for someone outside the lab.
Investor Brief
The one-page version built specifically for time-constrained decision-makers.
Impact Story
Frames the research's broader significance — the version built for public and media attention, not just funding.
See how this could work for your research.
No pressure, no obligation — just a straightforward conversation about your stage and your science.